Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method

被引:10
|
作者
Manduru, M
Mihm, LB
White, RL
Friedrich, LV
Flume, PA
Bosso, JA
机构
[1] MED UNIV S CAROLINA,COLL PHARM,QF 218,ANTIINFECT RES LAB,CHARLESTON,SC 29425
[2] MED UNIV S CAROLINA,COLL MED,DEPT MED,CHARLESTON,SC 29425
[3] MED UNIV S CAROLINA,COLL MED,DEPT PEDIAT,CHARLESTON,SC 29425
关键词
D O I
10.1128/AAC.41.11.2527
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bactericidal activity, historically assessed by in vitro tests which employ fixed drug concentrations, may also be evaluated in in vitro pharmacodynamic models in which in vivo pharmacokinetics and bacterial growth conditions can be simulated, However, systematic comparisons between the two methods are lacking, We evaluated the bactericidal activities of ceftazidime, at two different concentration/MIC ratios (C/MICs), against 10 clinical isolates of Pseudomonas aeruginosa in a two-compartment model with continuous-infusion conditions and a 2-h half-life. These values were compared to those determined by traditional 24-h time-kill (TTK) methods at the same C/MICs, Bactericidal activities were compared by using area under the colony count-time curves, Antibiotic exposure (area under the drug concentration-time curve) was also evaluated, Although bactericidal activity appeared greater by the TTK method (P = 0.05), when it was normalized for drug exposure, these differences disappeared (P = 0.2), This disparity was likely due to differences in drug exposure in the TTK method and in the peripheral compartment of the model (site of bacteria) over the first 8 h of the experiment, during which the antibiotic accumulated to target concentrations, This suggests that the bactericidal effects with constant antibiotic concentrations are similar in the two methods; however, this may not hold true with fluctuating drug concentrations, Further, results from the pharmacodynamic model may theoretically be more relevant, as in vivo pharmacokinetics and bacterial growth conditions can be more faithfully simulated.
引用
收藏
页码:2527 / 2532
页数:6
相关论文
共 50 条
  • [41] In vitro activity of ceftazidime/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected globally between 2016 and 2018
    Kiratisin, Pattarachai
    Kazmierczak, Krystyna
    Stone, Gregory G.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 27 : 132 - 141
  • [42] A PILOT STUDY OF THE IN VITRO INTERACTION OF FOSFOMYCIN AND MEROPENEM AGAINST METALL0-B-LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA USING ETEST AND TIME-KILL ASSAY
    Jahan, S.
    Davis, H.
    Ashcraft, D. S.
    Pankey, G. A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (02) : 647 - 648
  • [43] Comparative activities of selected fluoroquinolones against dynamic populations of Actinobacillus pleuropneumoniae in an in vitro model of time-kill continuous culture experiment
    Damte, Dereje
    Lee, Seung-Jin
    Yohannes, Sileshi B.
    Hossain, Md Akil
    Suh, Joo-Won
    Park, Seung-Chun
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (06) : 544 - 552
  • [44] Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa
    Sophonsri, Anthony
    Kalu, Michelle
    Wong-Beringer, Annie
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [45] Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology
    Kays, Michael B.
    Lisek, Christopher R.
    Denys, Gerald A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (03) : 289 - 294
  • [46] COMPARATIVE IN-VITRO KILLING ACTIVITY OF MEROPENEM VERSUS IMIPENEM AGAINST MULTIRESISTANT NOSOCOMIAL PSEUDOMONAS-AERUGINOSA
    GIAMARELLOSBOURBOULIS, EJ
    GRECKA, P
    GIAMARELLOU, H
    JOURNAL OF CHEMOTHERAPY, 1995, 7 (03) : 179 - 183
  • [47] In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)
    Walkty, A.
    DeCorby, M.
    Lagace-Wiens, P. R. S.
    Karlowsky, J. A.
    Hoban, D. J.
    Zhanel, G. G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2992 - 2994
  • [48] In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014-2017 and 2018
    Kristof, Katalin
    Adamkova, Vaclava
    Adler, Amos
    Gospodarek-Komkowska, Eugenia
    Rafila, Alexandru
    Billova, Sabina
    Mozejko-Pastewka, Barbara
    Kiss, Ferenc
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 101 (01)
  • [49] Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method
    Mezzatesta, Maria Lina
    Caio, Carla
    Gona, Floriana
    Zingali, Tiziana
    Salerno, Iasmine
    Stefani, Stefania
    MICROBIAL DRUG RESISTANCE, 2016, 22 (05) : 360 - 363
  • [50] Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries
    Garcia-Betancur, Juan Carlos
    De la Cadena, Elsa
    Mojica, Maria F.
    Hernandez-Gomez, Cristhian
    Correa, Adriana
    Radice, Marcela A.
    Castaneda-Mendez, Paulo
    Jaime-Villalon, Diego A.
    Gales, Ana C.
    Munita, Jose M.
    Villegas, Maria Virginia
    ANTIBIOTICS-BASEL, 2022, 11 (08):